In his new book The Problem of Alzheimer’s, Dr. Jason Karlawish from the Penn Memory Center traces the history of a condition that impacts nearly 6 million Americans at a cost of more than $225 billion annually. These numbers may triple over the next decade. In today’s episode, Dr. Karlawish discusses potential breakthroughs in the years ahead – both pharmacologic and social – that can help us weather this storm. We also review the FDA’s controversial approval last week of aducanumab, the first new drug for Alzheimer’s in nearly two decades.
**Be sure to subscribe to The Healthy Skeptic MD on your favorite podcast app and on Youtube!
Link for our channel on podcast apps and Youtube: wavve.link/healthyskepticmd